CNMD
CONMED Corp
-0.58 (-1.23%)46.46USD45.3K成交股數1.4B市值22.2本益比(近四季)1.0股價營收比+0.3%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 | 22Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 343M-1% | 338M+7% | 342M+3% | 321M+3% | 346M+14% | 317M-0% | 332M+12% | 312M+24% | 305M | 318M | 295M | 251M |
| 營業成本 | 146M | 172M | 154M | 144M | 148M | 138M | 148M | 140M | 137M | 147M | 140M | 119M |
| 毛利 | 197M-0% | 166M-7% | 188M+2% | 178M+3% | 198M+18% | 179M+5% | 184M+18% | 172M+30% | 168M | 171M | 155M | 132M |
| 毛利率 | 57.5% | 49.2% | 55.0% | 55.3% | 57.3% | 56.5% | 55.3% | 55.1% | 55.2% | 53.7% | 52.6% | 52.6% |
| 研發費用 | 15.5M | 13.9M | 14.1M | 12.9M | 13.2M | 13.6M | 14.1M | 13.6M | 12.5M | 13.6M | 12.5M | 12.2M |
| 銷售管理費用 | 146M | 140M | 136M | 149M | 133M | 99.7M | 123M | 123M | 125M | 130M | 130M | 121M |
| 營業利益 | 36.4M-31% | 11.9M-82% | 38.2M-19% | 16.0M-54% | 52.5M+73% | 65.7M+140% | 47.1M+271% | 35.0M-3295% | 30.3M | 27.4M | 12.7M | −1.1M |
| 營業利益率 | 10.6% | 3.5% | 11.1% | 5.0% | 15.2% | 20.7% | 14.2% | 11.2% | 9.9% | 8.6% | 4.3% | -0.4% |
| 稅後淨利 | 23.1M-32% | 2.9M-94% | 21.4M-29% | 6.0M-69% | 33.7M+113% | 49.0M+257% | 30.0M+1548% | 19.7M-26% | 15.8M | 13.7M | 1.8M | 26.6M |
| 淨利率 | 6.7% | 0.8% | 6.3% | 1.9% | 9.8% | 15.5% | 9.0% | 6.3% | 5.2% | 4.3% | 0.6% | 10.6% |
| 稀釋 EPS | 0.77-29% | 0.09-94% | 0.69-28% | 0.19-70% | 1.09+118% | 1.57+265% | 0.96+1500% | 0.63-38% | 0.50 | 0.43 | 0.06 | 1.02 |
| 稀釋股數 | 30.1M | 31.1M | 31.1M | 31.2M | 31.1M | 31.1M | 31.1M | 31.3M | 31.7M | 31.8M | 31.2M | 30.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 | 22Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 37.3M | 38.9M | 33.9M | 35.5M | 24.5M | 38.5M | 28.9M | 33.9M | 30.5M | 27.8M | 26.5M | 28.9M |
| 應收帳款 | 240M | 225M | 234M | 221M | 238M | 231M | 239M | 241M | 230M | 229M | 213M | 191M |
| 存貨 | 360M | 364M | 362M | 355M | 347M | 343M | 322M | 322M | 326M | 327M | 335M | 332M |
| 總資產 | 2.3B | 2.3B | 2.3B | 2.3B | 2.3B | 2.3B | 2.3B | 2.3B | 2.3B | 2.3B | 2.3B | 2.3B |
| 有息負債 | 657M | 853M | 881M | 891M | 905M | 940M | 965M | 990M | 942M | 971M | 995M | 985M |
| 總負債 | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B | 1.4B | 1.4B | 1.5B | 1.5B | 1.5B | 1.6B | 1.6B |
| 股東權益 | 1.0B | 1.0B | 1.0B | 978M | 963M | 933M | 882M | 855M | 796M | 780M | 752M | 746M |
| 負債比 | 54.7% | 56.6% | 56.9% | 57.5% | 58.3% | 59.7% | 61.4% | 63.0% | 65.8% | 66.4% | 67.6% | 67.6% |
| 淨現金(現金 − 有息負債) | −620M | −814M | −847M | −856M | −881M | −902M | −936M | −956M | −912M | −944M | −969M | −956M |
現金流量表 單季
| 科目 | 26Q2 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 | 22Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | – | 41.5M+43% | – | – | – | 29.1M | – | – | −3.8M | – |
| 資本支出 | – | – | – | 3.8M | – | – | – | 2.0M | – | – | 4.3M | – |
| 自由現金流 | – | – | – | 37.8M+39% | – | – | – | 27.1M | – | – | −8.1M | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | 6.2M | – | – | – | 6.2M | – | – | 6.1M | – |
| 自由現金流率 | – | – | – | 11.8% | – | – | – | 8.7% | – | – | -2.7% | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.4B | +5.2% | 47.1M | 3.4% | 1.51 | 151M |
| FY2024 | 1.3B | +5.0% | 132M | 10.1% | 4.25 | 154M |
| FY2023 | 1.2B | +19.1% | 64.5M | 5.2% | 2.04 | 106M |
| FY2022 | 1.0B | +3.4% | −80.6M | -7.7% | -2.68 | 11.6M |
| FY2021 | 1.0B | +17.2% | 62.5M | 6.2% | 1.94 | 96.9M |
| FY2020 | 862M | -9.7% | 9.5M | 1.1% | 0.32 | 51.5M |
| FY2019 | 955M | +11.1% | 28.6M | 3.0% | 0.97 | 75.1M |
| FY2018 | 860M | – | 40.9M | 4.8% | 1.41 | 58.2M |